TIME FROM HIV SEROCONVERSION TO ORAL CANDIDIASIS OR HAIRY LEUKOPLAKIAAMONG HOMOSEXUAL AND BISEXUAL MEN ENROLLED IN 3 PROSPECTIVE COHORTS

Citation
Ar. Lifson et al., TIME FROM HIV SEROCONVERSION TO ORAL CANDIDIASIS OR HAIRY LEUKOPLAKIAAMONG HOMOSEXUAL AND BISEXUAL MEN ENROLLED IN 3 PROSPECTIVE COHORTS, AIDS, 8(1), 1994, pp. 73-79
Citations number
42
Categorie Soggetti
Immunology,"Infectious Diseases
Journal title
AIDSACNP
ISSN journal
02699370
Volume
8
Issue
1
Year of publication
1994
Pages
73 - 79
Database
ISI
SICI code
0269-9370(1994)8:1<73:TFHSTO>2.0.ZU;2-2
Abstract
Objectives: We evaluated time from HIV seroconversion to diagnosis of two common oral lesions associated with HIV infection and disease prog ression. Design: Oral examinations were performed on homosexual and bi sexual men enrolled in prospective cohorts. Setting: Homosexual and bi sexual men were followed in three epidemiologic cohort studies in San Francisco, California, USA. Participants: Data were evaluated from 80 men with well-defined dates of HIV seroconversion from 1984 through 19 91. Main outcome measures: We determined the cumulative incidence of o ral candidiasis and hairy leukoplakia after HIV seroconversion. Result s: Four per cent of men developed oral candidiasis within 1 year after HIV seroconversion, 8% within 2, 15% within 3, 18% within 4, and 26% within 5 years. Nine per cent developed hairy leukoplakia within 1 yea r, 16% within 2, 25% within 3, 35% within 4, and 42% within 5 years. T he median CD4+ count was 391 x 10(6)/l when oral candidiasis was first reported and 468 x 10(6)/l when hairy leukoplakia was first reported. Conclusions: Oral candidiasis or hairy leukoplakia appeared in a sign ificant proportion of HIV-infected homosexual and bisexual men. These lesions occurred relatively soon after HIV seroconversion, typically b efore AIDS. Evaluation of HIV-infected individuals for these lesions h as many potential clinical and research benefits, including the possib le use of oral lesions as primary end-points in clinical trials.